Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

JOHNSON & JOHNSON Director's Dealing 2004

Feb 18, 2004

29750_dirs_2004-02-17_e3f59b60-a22d-4f22-9929-aee805ed9701.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: PROTEIN POLYMER TECHNOLOGIES INC (PPTI.OB)
CIK: 0000858155
Period of Report: 2003-12-31

Reporting Person: JOHNSON & JOHNSON (10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2003-03-10 Series I Preferred Stock $.55 P 10000 Acquired Common Stock (1818181) Indirect
2003-03-10 Series I First Common Stock Warrants (Right to Buy) $.88 P 272727 Acquired 2004-09-30 Common Stock (272727) Indirect
2003-03-10 Series I Second Common Stock Warrants (Right to Buy) $1.65 P 181818 Acquired 2007-03-31 Common Stock (181818) Indirect

Footnotes

F1: There is no expiration date applicable to the Series I Preferred Stock.

F2: The securities reported as being indirectly beneficially owned by the Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the Reporting Person.

F3: The warrants were issued in conjunction with the purchase of Series I Preferred Stock.